New User:

-or-
Username:
Password:
Forgot your password?

Stock Market & Financial Investment News

News Breaks
June 9, 2014
13:25 EDTABT, ABT, DXCM, DXCM, JNJ, JNJ, MDT, MDT, PODD, PODD, TNDM, TNDMLeerink medical devices analyst holds an analyst/industry conference call
Medical Devices Analyst Antalffy provides a preview of the upcoming American Diabetes Association's 74th Scientific Sessions on an Analyst/Industry conference call. Relevant companies ABT, DXCM, JNJ, MDT, PODD and TNDM may be discussed on the Analyst/Industry conference call to be held on June 12 at 2 pm.
News For ABT;DXCM;JNJ;MDT;PODD;TNDM From The Last 14 Days
Sign up for a free trial to see the rest of the stories you've been missing.
1 | 2 | all recent news | >>
July 29, 2015
19:35 EDTPODDInsulet backs FY15 revenue guidance of $305M-$320M, consensus $302.65M
Subscribe for More Information
19:35 EDTPODDInsulet sees Q3 revenue $82M-$85M, consensus $83.6M
19:34 EDTPODDInsulet reports preliminary Q2 revenue $75.6M, consensus $68.95M
Subscribe for More Information
19:33 EDTPODDInsulet postpones release fo full Q2 results
Subscribe for More Information
12:17 EDTJNJMedivation plummets after Cowen highlights slowing Xtandi trends
Subscribe for More Information
11:23 EDTJNJMedivir says Janssen's Alios BIopharma starts Phase I AL-704 trial
Subscribe for More Information
July 28, 2015
07:05 EDTJNJMacroGenics reports MGD011 advances into clinical development
Subscribe for More Information
July 27, 2015
10:40 EDTJNJLeerink major pharma analyst holds an analyst/industry conference call
Subscribe for More Information
July 23, 2015
17:51 EDTJNJJanssen submits sNDA to update label for Olysio
Subscribe for More Information
July 22, 2015
10:15 EDTJNJ, MDTThoratec downgraded to Market Perform from Outperform at Northland
Subscribe for More Information
10:06 EDTABTAbbott CEO says supportive of Mylan pursuit of Perrigo
Subscribe for More Information
09:33 EDTABTAbbott sees Q3 Diagnostics sales up mid single digits on operational basis
Subscribe for More Information
09:30 EDTABTAbbott CEO says 'pretty alligned' with Mylan so far
09:15 EDTABTAbbott sees FY15 reported sales growth to be in low single digits
Subscribe for More Information
09:15 EDTABTAbbott sees Q3 EPS 52c-54c, consensus 55c
Sees Q3 impact from foreign exchange to be "somewhat above" 9% based on current exchange rates, resulting in reported sales growth in the low single digits, consensus $5.19B. Guidance from Q2 earnings call.
09:07 EDTABTOn The Fly: Pre-market Movers
Subscribe for More Information
09:07 EDTABTAbbott says foreign exchange impacting results more than expected in January
Subscribe for More Information
07:49 EDTABTAbbott reports Q2 Nutrition sales $1.72B, Diagnostics sales $1.18B
Subscribe for More Information
07:48 EDTABTAbbott backs FY15 adjusted EPS $2.10-$2.20, consensus $2.16
Abbott forecasts net specified items related to continuing operations for the full year 2015 of approximately 60c per share.
07:47 EDTABTAbbott reports Q2 adjusted EPS 52c, consensus 50c
Subscribe for More Information
1 | 2 | all recent news | >>

Sign up for a free trial to see the rest of the stories you've been missing.

I agree to the theflyonthewall.com disclaimer & terms of use